Peripheral blood mononuclear cells inhibit proliferation and promote apoptosis of HeLa cells following stimulation with Bacillus Calmette-Guerin

Experimental and Therapeutic Medicine

Volumn 5, Issue 2, 2013, Pages 561-566

  Lu, Xiaoqing ^a   Wu, Lingjiao ^a   Liu, Zhuo ^b   Xie, Liping ^a   Wang, Shuo ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

Bacillus Calmette Guerin immunotherapy; Bacillus Calmette Guerin activated killer cells; HeLa cells; Human papilloma virus E7; Peripheral blood mononuclear cells; Retinoblastoma E2F1 pathway

Indexed keywords

BCG VACCINE; PROTEIN E7; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; FLOW CYTOMETRY; HELA CELL; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; INCUBATION TIME; PAPILLOMAVIRUS INFECTION; PERIPHERAL BLOOD MONONUCLEAR CELL; UTERINE CERVIX CANCER;

EID: 84871350227     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.855     Document Type: Article

References (22)

1. Babjuk M: New insights in intravesical treatment for intermediate-and high-risk non-muscle-invasive urothelial bladder carcinoma. Eur Urol 57: 774-776, 2010.
2. Shelley MD, Mason MD and Kynaston H: Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses. Cancer Treat Rev 36: 195-205, 2010.
3. Brandau S, Riemensberger J, Jacobsen M, et al: NK cells are essential for effective BCG immunotherapy. Int J Cancer 92: 697-702, 2001.
4. Brandau S and Böhle A: Activation of natural killer cells by Bacillus Calmette-Guérin. Eur Urol 39: 518-524, 2001.
5. Brandau S, Suttmann H, Riemensberger J, et al: Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells. Clin Cancer Res6: 3729-3738, 2000.
6. Metawea B, El-Nashar AR, Kamel I, Kassem W and ShamloulR: Application of viable bacille Calmette-Guérin topically as a potential therapeutic modality in condylomata acuminata: a placebo-controlled study. Urology 65: 247-250, 2005.
7. Böhle A, Büttner H and Jocham D: Primary treatment of condylomata acuminata with viable bacillus Calmette-Guerin. JUrol165: 834-836, 2001.
8. Fayed ST, Amer M, Ammar E and Salam MA: Local BCG injection administered to patients with flat condyloma of the cervix. Int J Gynaecol Obstet 107: 253-254, 2009.
9. Singh S, Johnson J and Chellappan S: Small molecule regulators of RB-E2F pathway as modulators of transcription. Biochim Biophys Acta 1799: 788-794, 2010.
10. Cormio L, Tolve I, Annese P, et al: Altered p53 and pRB expression is predictive of response to BCG treatment in T1G3 bladder cancer. Anticancer Res 29: 4201-4204, 2009.
11. Esuvaranathan K, Chiong E, Thamboo TP, et al: Predictive value of p53 and pRB expression in superficial bladder cancer patients treated with BCG and interferon-alpha. Cancer 109: 1097-1105, 2007.
12. Thänhauser A, Böhle A, Flad HD, Ernst M, Mattern T and UlmerAJ: Induction of bacillus-Calmette-Guérin-activated killer cells from human peripheral blood mononuclear cells against human bladder carcinoma cell lines in vitro. Cancer Immunol Immunother 37: 105-111, 1993.
13. Suttmann H, Jacobsen M, Reiss K, Jocham D, Böhle A and Brandau S: Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation. J Urol 172: 1490-1495, 2004.
14. Moretta A: Molecular mechanisms in cell-mediated cytotoxicity. Cell 90: 13-18, 1997.
15. Münger K and Howley PM: Human papillomavirus immortalization and transformation functions. Virus Res 89: 213-228, 2002.
16. Cobrinik D: Pocket proteins and cell cycle control. Oncogene 24: 2796-2809, 2005.
17. Bremner R and Zacksenhaus E: Cyclins, Cdks, E2f, Skp2, and more at the first international RB Tumor Suppressor Meeting. Cancer Res 70: 6114-6118, 2010.
18. Deshpande A, Sicinski P and Hinds PW: Cyclins and cdks in development and cancer: a perspective. Oncogene 24: 2909-2915, 2005.
19. Chau BN and Wang JY: Coordinated regulation of life and death by RB. Nat Rev Cancer 3: 130-138, 2003.
20. Ruiz S, Santos M, Segrelles C, et al: Unique and overlapping functions of pRB and p107 in the control of proliferation and differentiation in epidermis. Development 131: 2737-2748, 2004.
21. Wise-Draper TM and Wells SI: Papillomavirus E6 and E7 proteins and their cellular targets. Front Biosci 13: 1003-1017, 2008.
22. Mitra AP, Birkhahn M and Cote RJ: p53 and retinoblastoma pathways in bladder cancer. World J Urol 25: 563-571, 2007.